ReviewBreast cancer (Dove Medical Press)2023

Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review.

Jin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.